412 related articles for article (PubMed ID: 20600326)
1. Murine bone marrow chimeras developing autoimmunity after CTLA-4-blockade show an expansion of T regulatory cells with an activated cytokine profile.
De Somer L; Fevery S; Bullens DM; Rutgeerts O; Lenaerts C; Mathieu C; Boon L; Kasran A; Waer M; Billiau AD
Immunol Lett; 2010 Sep; 133(1):49-53. PubMed ID: 20600326
[TBL] [Abstract][Full Text] [Related]
2. CTLA-4 x Ig converts naive CD4+CD25- T cells into CD4+CD25+ regulatory T cells.
Razmara M; Hilliard B; Ziarani AK; Chen YH; Tykocinski ML
Int Immunol; 2008 Apr; 20(4):471-83. PubMed ID: 18272926
[TBL] [Abstract][Full Text] [Related]
3. Endothelial cells augment the suppressive function of CD4+ CD25+ Foxp3+ regulatory T cells: involvement of programmed death-1 and IL-10.
Bedke T; Pretsch L; Karakhanova S; Enk AH; Mahnke K
J Immunol; 2010 May; 184(10):5562-70. PubMed ID: 20382886
[TBL] [Abstract][Full Text] [Related]
4. In-vitro generation and characterisation of murine CD4+CD25+ regulatory T cells with indirect allospecificity.
Tsang J; Jiang S; Tanriver Y; Leung E; Lombardi G; Lechler RI
Int Immunopharmacol; 2006 Dec; 6(13-14):1883-8. PubMed ID: 17161341
[TBL] [Abstract][Full Text] [Related]
5. Systemic CTLA-4 blockade ameliorates glioma-induced changes to the CD4+ T cell compartment without affecting regulatory T-cell function.
Fecci PE; Ochiai H; Mitchell DA; Grossi PM; Sweeney AE; Archer GE; Cummings T; Allison JP; Bigner DD; Sampson JH
Clin Cancer Res; 2007 Apr; 13(7):2158-67. PubMed ID: 17404100
[TBL] [Abstract][Full Text] [Related]
6. Stimulation of α7 nicotinic acetylcholine receptor by nicotine increases suppressive capacity of naturally occurring CD4+CD25+ regulatory T cells in mice in vitro.
Wang DW; Zhou RB; Yao YM; Zhu XM; Yin YM; Zhao GJ; Dong N; Sheng ZY
J Pharmacol Exp Ther; 2010 Dec; 335(3):553-61. PubMed ID: 20843956
[TBL] [Abstract][Full Text] [Related]
7. Systemic anti-CD25 monoclonal antibody administration safely enhances immunity in murine glioma without eliminating regulatory T cells.
Fecci PE; Sweeney AE; Grossi PM; Nair SK; Learn CA; Mitchell DA; Cui X; Cummings TJ; Bigner DD; Gilboa E; Sampson JH
Clin Cancer Res; 2006 Jul; 12(14 Pt 1):4294-305. PubMed ID: 16857805
[TBL] [Abstract][Full Text] [Related]
8. Costimulation blockade-induced cardiac allograft tolerance: inhibition of T cell expansion and accumulation of intragraft cD4(+)Foxp3(+) T cells.
Oderup C; Malm H; Ekberg H; Qi Z; Veress B; Ivars F; Corbascio M
Transplantation; 2006 Dec; 82(11):1493-500. PubMed ID: 17164722
[TBL] [Abstract][Full Text] [Related]
9. Mast cells down-regulate CD4+CD25+ T regulatory cell suppressor function via histamine H1 receptor interaction.
Forward NA; Furlong SJ; Yang Y; Lin TJ; Hoskin DW
J Immunol; 2009 Sep; 183(5):3014-22. PubMed ID: 19667094
[TBL] [Abstract][Full Text] [Related]
10. CD4(+)CD25 (+) regulatory T cells in human lupus erythematosus.
Kuhn A; Beissert S; Krammer PH
Arch Dermatol Res; 2009 Jan; 301(1):71-81. PubMed ID: 18985367
[TBL] [Abstract][Full Text] [Related]
11. CTLA-4 blockade in murine bone marrow chimeras induces a host-derived antileukemic effect without graft-versus-host disease.
Fevery S; Billiau AD; Sprangers B; Rutgeerts O; Lenaerts C; Goebels J; Landuyt W; Kasran A; Boon L; Sagaert X; De Wolf-Peeters C; Waer M; Vandenberghe P
Leukemia; 2007 Jul; 21(7):1451-9. PubMed ID: 17508005
[TBL] [Abstract][Full Text] [Related]
12. Insufficient increment of CD4+CD25+ regulatory T cells after stimulation in vitro with allergen in allergic asthma.
Wang LH; Lin YH; Yang J; Guo W
Int Arch Allergy Immunol; 2009; 148(3):199-210. PubMed ID: 18849611
[TBL] [Abstract][Full Text] [Related]
13. The levels of CD4+CD25+ regulatory T cells in paediatric patients with allergic rhinitis and bronchial asthma.
Lee JH; Yu HH; Wang LC; Yang YH; Lin YT; Chiang BL
Clin Exp Immunol; 2007 Apr; 148(1):53-63. PubMed ID: 17349011
[TBL] [Abstract][Full Text] [Related]
14. Correlation between the degree of immune activation, production of IL-2 and FOXP3 expression in CD4+CD25+ T regulatory cells in HIV-1 infected persons under HAART.
Terzieva V; Popova D; Kicheva M; Todorova Y; Markova R; Martinova F; Elenkov I; Yankova M
Int Immunopharmacol; 2009 Jul; 9(7-8):831-6. PubMed ID: 19303058
[TBL] [Abstract][Full Text] [Related]
15. Natural killer cells prevent CD28-mediated Foxp3 transcription in CD4+CD25- T lymphocytes.
Brillard E; Pallandre JR; Chalmers D; Ryffel B; Radlovic A; Seilles E; Rohrlich PS; Pivot X; Tiberghien P; Saas P; Borg C
Exp Hematol; 2007 Mar; 35(3):416-25. PubMed ID: 17309822
[TBL] [Abstract][Full Text] [Related]
16. TGF-beta1 modulates Foxp3 expression and regulatory activity in distinct CD4+ T cell subsets.
Pyzik M; Piccirillo CA
J Leukoc Biol; 2007 Aug; 82(2):335-46. PubMed ID: 17475784
[TBL] [Abstract][Full Text] [Related]
17. Dendritic cells partially abrogate the regulatory activity of CD4+CD25+ T cells present in the human peripheral blood.
Ahn JS; Krishnadas DK; Agrawal B
Int Immunol; 2007 Mar; 19(3):227-37. PubMed ID: 17289657
[TBL] [Abstract][Full Text] [Related]
18. Bcl-xL is required for the development of functional regulatory CD4 cells in lupus-afflicted mice following treatment with a tolerogenic peptide.
Sharabi A; Lapter S; Mozes E
J Autoimmun; 2010 Mar; 34(2):87-95. PubMed ID: 19596183
[TBL] [Abstract][Full Text] [Related]
19. Increased CD4+CD25+Foxp3+ regulatory T cells in tolerance induced by portal venous injection.
He F; Chen Z; Xu S; Cai M; Wu M; Li H; Chen X
Surgery; 2009 Jun; 145(6):663-74. PubMed ID: 19486771
[TBL] [Abstract][Full Text] [Related]
20. Blockade of CTLA-4 decreases the generation of multifunctional memory CD4+ T cells in vivo.
Rudolph M; Hebel K; Miyamura Y; Maverakis E; Brunner-Weinzierl MC
J Immunol; 2011 May; 186(10):5580-9. PubMed ID: 21478403
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]